ID

39884

Beschrijving

A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas; ODM derived from: https://clinicaltrials.gov/show/NCT01985958

Link

https://clinicaltrials.gov/show/NCT01985958

Trefwoorden

  1. 27-02-20 27-02-20 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

27 februari 2020

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Histological or Cytological Diagnosis of Pancreatic Carcinoma NCT01985958

Eligibility Histological or Cytological Diagnosis of Pancreatic Carcinoma NCT01985958

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
histological or cytological diagnosis of pancreatic carcinoma
Beschrijving

Pancreatic carcinoma

Datatype

boolean

Alias
UMLS CUI [1]
C0235974
patients ≥ 18 years of age
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
eastern cooperative oncology group (ecog) performance status 0,1,or 2
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
patients must have distant metastatic disease (stage 4)
Beschrijving

Distant metastasis

Datatype

boolean

Alias
UMLS CUI [1]
C1269798
satisfactory organ and bone marrow function as defined by: absolute neutrophil count> 1,000/ul, platelets > 75,000ul hemoglobin > 9 bilirubin ≤ 2.0x the institutional normal upper limit unless secondary to bile duct obstruction by tumor,
Beschrijving

Organ function | Bone Marrow function | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement | Serum total bilirubin measurement | Exception Secondary to Cholestasis | Cholestasis Due to Tumor

Datatype

boolean

Alias
UMLS CUI [1]
C0678852
UMLS CUI [2,1]
C0005953
UMLS CUI [2,2]
C0031843
UMLS CUI [3]
C0948762
UMLS CUI [4]
C0032181
UMLS CUI [5]
C0518015
UMLS CUI [6]
C1278039
UMLS CUI [7,1]
C1705847
UMLS CUI [7,2]
C0175668
UMLS CUI [7,3]
C0008370
UMLS CUI [8,1]
C0008370
UMLS CUI [8,2]
C0678226
UMLS CUI [8,3]
C0027651
creatinine ≤ 1.5x the institutional normal upper limit
Beschrijving

Creatinine measurement, serum

Datatype

boolean

Alias
UMLS CUI [1]
C0201976
serum alanine aminotransferase (alt) or aspartate aminotransferase (ast) ≤ 5x the institutional normal upper limit.
Beschrijving

Alanine aminotransferase measurement | Aspartate aminotransferase measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
a clinical recommendation for radiotherapy to the primary or a metastatic lesion had been made.
Beschrijving

Recommendation Therapeutic radiology procedure Primary Lesion | Recommendation Therapeutic radiology procedure Metastatic Lesion

Datatype

boolean

Alias
UMLS CUI [1,1]
C0034866
UMLS CUI [1,2]
C1522449
UMLS CUI [1,3]
C1402294
UMLS CUI [2,1]
C0034866
UMLS CUI [2,2]
C1522449
UMLS CUI [2,3]
C1513183
must be able to provide informed consent.
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
no prior radiation to the area planned for radiotherapy
Beschrijving

Prior radiation therapy Area Planned Therapeutic radiology procedure

Datatype

boolean

Alias
UMLS CUI [1,1]
C0279134
UMLS CUI [1,2]
C0205146
UMLS CUI [1,3]
C1301732
UMLS CUI [1,4]
C1522449
active invasive cancer other than pancreatic adenocarcinoma. non-melanoma skin cancer, superficial cervical or bladder cancer and prostate cancer with psa level < 1.0 are not excluded.
Beschrijving

Invasive cancer | Exception Adenocarcinoma of pancreas | Exception Skin carcinoma | Exception Superficial cervix carcinoma | Exception Superficial carcinoma of urinary bladder | Exception Prostate carcinoma PSA Level

Datatype

boolean

Alias
UMLS CUI [1]
C0677898
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0281361
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0699893
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0302592
UMLS CUI [4,3]
C0205124
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C1336527
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0600139
UMLS CUI [6,3]
C4086720
known hiv, hcv and/or hbv positive (by patient report/medical record)
Beschrijving

HIV Seropositivity | Hepatitis C Virus Positive | Hepatitis B Virus Positive

Datatype

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C4330254
UMLS CUI [3,1]
C0019169
UMLS CUI [3,2]
C1514241
patients with ongoing or active infection
Beschrijving

Communicable Disease

Datatype

boolean

Alias
UMLS CUI [1]
C0009450
planned concurrent treatment with systemic high dose corticosteroids.
Beschrijving

CORTICOSTEROIDS FOR SYSTEMIC USE High dose Planned

Datatype

boolean

Alias
UMLS CUI [1,1]
C3653708
UMLS CUI [1,2]
C0444956
UMLS CUI [1,3]
C1301732
received an anticancer treatment (systemic therapy or radiation therapy)within 21 days prior to enrollment.
Beschrijving

Cancer treatment | Systemic therapy | Therapeutic radiology procedure

Datatype

boolean

Alias
UMLS CUI [1]
C0920425
UMLS CUI [2]
C1515119
UMLS CUI [3]
C1522449
immunotherapy (e.g. monoclonal antibodies)within 21 days prior to enrollment.
Beschrijving

Immunotherapy | Monoclonal Antibodies

Datatype

boolean

Alias
UMLS CUI [1]
C0021083
UMLS CUI [2]
C0003250
immunosuppressive therapies (e.g. steroids, cyclosporine) are not permitted.
Beschrijving

Therapeutic immunosuppression | Steroid therapy | Cyclosporine

Datatype

boolean

Alias
UMLS CUI [1]
C0021079
UMLS CUI [2]
C0149783
UMLS CUI [3]
C0010592

Similar models

Eligibility Histological or Cytological Diagnosis of Pancreatic Carcinoma NCT01985958

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Pancreatic carcinoma
Item
histological or cytological diagnosis of pancreatic carcinoma
boolean
C0235974 (UMLS CUI [1])
Age
Item
patients ≥ 18 years of age
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0,1,or 2
boolean
C1520224 (UMLS CUI [1])
Distant metastasis
Item
patients must have distant metastatic disease (stage 4)
boolean
C1269798 (UMLS CUI [1])
Organ function | Bone Marrow function | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement | Serum total bilirubin measurement | Exception Secondary to Cholestasis | Cholestasis Due to Tumor
Item
satisfactory organ and bone marrow function as defined by: absolute neutrophil count> 1,000/ul, platelets > 75,000ul hemoglobin > 9 bilirubin ≤ 2.0x the institutional normal upper limit unless secondary to bile duct obstruction by tumor,
boolean
C0678852 (UMLS CUI [1])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
C0948762 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
C0518015 (UMLS CUI [5])
C1278039 (UMLS CUI [6])
C1705847 (UMLS CUI [7,1])
C0175668 (UMLS CUI [7,2])
C0008370 (UMLS CUI [7,3])
C0008370 (UMLS CUI [8,1])
C0678226 (UMLS CUI [8,2])
C0027651 (UMLS CUI [8,3])
Creatinine measurement, serum
Item
creatinine ≤ 1.5x the institutional normal upper limit
boolean
C0201976 (UMLS CUI [1])
Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
serum alanine aminotransferase (alt) or aspartate aminotransferase (ast) ≤ 5x the institutional normal upper limit.
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
Recommendation Therapeutic radiology procedure Primary Lesion | Recommendation Therapeutic radiology procedure Metastatic Lesion
Item
a clinical recommendation for radiotherapy to the primary or a metastatic lesion had been made.
boolean
C0034866 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C1402294 (UMLS CUI [1,3])
C0034866 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
C1513183 (UMLS CUI [2,3])
Informed Consent
Item
must be able to provide informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior radiation therapy Area Planned Therapeutic radiology procedure
Item
no prior radiation to the area planned for radiotherapy
boolean
C0279134 (UMLS CUI [1,1])
C0205146 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
C1522449 (UMLS CUI [1,4])
Invasive cancer | Exception Adenocarcinoma of pancreas | Exception Skin carcinoma | Exception Superficial cervix carcinoma | Exception Superficial carcinoma of urinary bladder | Exception Prostate carcinoma PSA Level
Item
active invasive cancer other than pancreatic adenocarcinoma. non-melanoma skin cancer, superficial cervical or bladder cancer and prostate cancer with psa level < 1.0 are not excluded.
boolean
C0677898 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0281361 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0699893 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0302592 (UMLS CUI [4,2])
C0205124 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C1336527 (UMLS CUI [5,2])
C1705847 (UMLS CUI [6,1])
C0600139 (UMLS CUI [6,2])
C4086720 (UMLS CUI [6,3])
HIV Seropositivity | Hepatitis C Virus Positive | Hepatitis B Virus Positive
Item
known hiv, hcv and/or hbv positive (by patient report/medical record)
boolean
C0019699 (UMLS CUI [1])
C4330254 (UMLS CUI [2])
C0019169 (UMLS CUI [3,1])
C1514241 (UMLS CUI [3,2])
Communicable Disease
Item
patients with ongoing or active infection
boolean
C0009450 (UMLS CUI [1])
CORTICOSTEROIDS FOR SYSTEMIC USE High dose Planned
Item
planned concurrent treatment with systemic high dose corticosteroids.
boolean
C3653708 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
Cancer treatment | Systemic therapy | Therapeutic radiology procedure
Item
received an anticancer treatment (systemic therapy or radiation therapy)within 21 days prior to enrollment.
boolean
C0920425 (UMLS CUI [1])
C1515119 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
Immunotherapy | Monoclonal Antibodies
Item
immunotherapy (e.g. monoclonal antibodies)within 21 days prior to enrollment.
boolean
C0021083 (UMLS CUI [1])
C0003250 (UMLS CUI [2])
Therapeutic immunosuppression | Steroid therapy | Cyclosporine
Item
immunosuppressive therapies (e.g. steroids, cyclosporine) are not permitted.
boolean
C0021079 (UMLS CUI [1])
C0149783 (UMLS CUI [2])
C0010592 (UMLS CUI [3])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial